NEOGENOMICS INC (NEO)
US64049M2098 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 331.91M | 342.49M | 263.20M | 316.80M | 228.70M | |||
| Marketable Securities | 52.92M | 72.72M | 174.80M | 198.60M | 67.50M | |||
| Receivables | 140.51M | 131.26M | 121.60M | 113.90M | 108.50M | |||
| Inventories | 20.32M | 24.16M | 24.30M | 23.40M | 29.50M | |||
| Other Current Assets | 28.23M | 26.19M | 21.40M | 28.90M | 14.40M | |||
| Total Current Assets | 573.90M | 596.81M | 605.30M | 681.50M | 448.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 174.44M | 183.78M | 198.60M | 211.70M | 131.70M | |||
| Investments And Advances | N/A | N/A | N/A | 0.00 | 29.60M | |||
| Goodwill | 522.77M | 522.77M | 522.80M | 527.10M | 211.10M | |||
| Intangibles | 364.76M | 373.13M | 408.30M | 442.30M | 120.70M | |||
| Other Non-Current Assets | 4.47M | 4.74M | 5.10M | 6.90M | 46.40M | |||
| Total Non-Current Assets | 1.07B | 1.08B | 1.13B | 1.19B | 539.60M | |||
| TOTAL ASSETS | 1.64B | 1.68B | 1.74B | 1.87B | 988.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 100.00K | 1.10M | 2.80M | |||
| Accrued Expenses | 57.23M | 73.84M | 61.80M | 63.00M | 41.30M | |||
| Accounts Payable | 18.34M | 20.33M | 20.50M | 17.90M | 25.00M | |||
| Other Current Liabilities | 1.14M | 2.13M | 7.60M | 5.20M | 4.00M | |||
| Total Current Liabilities | 76.71M | 96.30M | 89.90M | 87.20M | 73.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 538.92M | 538.20M | 535.30M | 532.60M | 169.10M | |||
| Deferred Taxes/Income | 23.49M | 24.29M | 34.80M | 55.50M | 5.40M | |||
| Other Non-Current Liabilities | 77.81M | 80.91M | 82.00M | 86.20M | 46.40M | |||
| Total Non-Current Liabilities | 640.22M | 643.39M | 652.10M | 674.30M | 220.80M | |||
| TOTAL LIABILITIES | 716.93M | 739.69M | 742.00M | 761.50M | 294.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -274.12M | -247.06M | -159.10M | -14.80M | -7.20M | |||
| Additional Paid In Capital | 1.20B | 1.19B | 1.16B | 1.12B | 701.40M | |||
| Common Shares | 127.00K | 127.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | -1.33M | -1.67M | -3.90M | -600.00K | 0.00 | |||
| Shares Outstanding | 127.43M | 127.37M | 126.90M | 124.10M | 112.10M | |||
| Tangible Book Value per Share | 0.28 | 0.36 | 0.53 | 1.12 | 3.23 | |||
| Total Shareholders' Equity | 923.41M | 941.54M | 998.00M | 1.11B | 694.30M | |||
| TOTAL LIABILITIES AND EQUITY | 1.64B | 1.68B | 1.74B | 1.87B | 988.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.58 | 0.57 | 0.54 | 0.48 | 0.24 | |||
| Current Ratio | 7.48 | 6.20 | 6.73 | 7.82 | 6.13 | |||
| Return On Assets (ROA) | -5.13% | -5.23% | -8.29% | -0.44% | 0.42% | |||
| Return On Equity (ROE) | -9.12% | -9.34% | -14.46% | -0.75% | 0.60% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD